Mental Disorders

286 trials 120 recruiting

Filter these 286 trials by phase, country and sponsor.

Open in Search →

Long-term outcomes and safety of repeated rituximab treatment in psychotic disorders – RITS-LONG Pending

2026-525324-26-00 Schizophrenia spectrum disorder (SSD) 4
POSITRON - PsilOcybin with pSychologIcal supporT foR cOcaiNe: a randomised controlled pilot feasibility trial of psilocybin with psychologic… Pending

2024-515147-32-02 Cocaine addiction 4
The therapeutic potential of psilocybin in anorexia nervosa in young adults Pending

2024-515163-63-00 Anorexia Nervosa 4
Use of low doses of interleukin-2 in autism spectrum disorders Pending

2025-522841-23-00 Autism Spectrum disorder ASD 4
Antidepressant effects of psilocybin without the psychedelic serotonin experience: A dimensional approach using functional neuroimaging. Pending

2025-521690-14-00 Major depressive disorder 4
An Open-label Study of Azetukalner in Bipolar I or II Depression Pending

2025-522872-10-00 Depressive episodes associated with Bipolar disorder I 5
A Randomized, Multiple-Dose, Open-Label, Parallel-Group Study to Evaluate the Pharmacokinetic Profiles of LY03010 and the Relative Bioavaila… Pending

2023-508981-13-00 Schizophrenia 2
OSU6162 as add-on in SSRI/SNRI-resistant depression (ODEN): a double-blind, placebo-controlled evaluation of efficacy and safety Pending

2024-513894-35-00 Depression 4
FELICITA - A proof of concept study: open label phase IIa trial evaluating the effect and safety of transplantation of fecal microbiota in c… Pending

2025-520539-17-00 Austistic spectrum disorder 4
TMSxDCS: Medicinal improvement of brain stimulation for depression. Pending

2025-521166-95-00 Major Depressive Disorder (MDD) 4
A randomized controlled trial of the effect of anesthetic dose during electroconvulsive therapy for major depression Pending

2024-519407-99-00 Major depressive disorder 6
Efficiency of a composite personalised care on functional outcome in early psychosis: A Prospective Randomised Controlled Trial Pending

2025-520573-39-00 Ultra High Risk of psychosis and first episode psychos 6
An Open-Label Study of ML-007C-MA in Adults with Alzheimer’s Disease Psychosis Pending

2025-521757-16-00 Hallucinations and Delusions Associated with Alzheimer’ 4
Ketamine infusion for symptomatological improvement of severe borderline personality disorder: a pilot study Pending

2024-514361-19-00 borderline personality disorder 4
The Acute and Long-term Impact of Support in Psilocybin Therapy for Depression: The Psilocybin Setting Trial (PSISET) Pending

2025-522961-31-01 Depression 4
Clinical trial to evaluate the effectiveness and efficiency of a pre-emptive pharmacogenetic strategy for antidepressant selection in patien… Pending

2025-522967-13-00 Depressive disorder 6
A Phase 3 Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (13 to 17 years of age) Pending

2025-523711-11-00 Schizophrenia 5
A prospective, randomized, and controlled study comparing two treatment strategies (Dose REduction of Antipsychotics vs. Maintenance treatme… Pending

2023-509558-80-00 Patient with a diagnosis of schizophrenia spectrum diso 5
Etude de phase II évaluant la capacité d'un agoniste des récepteurs 5-HT4, le prucalopride (Resolor©), à accélérer l'efficacité thérapeutiqu… Pending

2025-521811-38-01 Dépression 4
A PET Study to Assess the Occupancy of M4 Muscarinic Acetylcholine Receptors by BMS-986521 in Healthy Adult Participants Pending

2025-524564-38-00 Neuropsychiatric indications and potentially other cond 3
UNPRESCRIB-D Pending

2026-526314-90-00 Major Depressive Disorder 6
Effect of Minocycline on Inflammation in Depressed Patients Pending

2024-520076-10-01 Depression 4
RESET-TRD; a Randomised trial on oral ESketamine compared to Electroconvulsive Therapy for patients with Treatment Resistant Depression Pending

2024-517485-42-00 Non-psychotic therapy resistant unipolar depression 5
Effect of faecal microbiota transplant on the expression of autism spectrum disorder core symptoms in children – open-label phase II clinica… Pending

2025-524673-16-00 Autism spectrum disorder 4